BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20622039)

  • 21. Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry.
    Zhang S; Patel HH; Murray F; Remillard CV; Schach C; Thistlethwaite PA; Insel PA; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2007 May; 292(5):L1202-10. PubMed ID: 17189322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.
    Ali FY; Egan K; FitzGerald GA; Desvergne B; Wahli W; Bishop-Bailey D; Warner TD; Mitchell JA
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):242-6. PubMed ID: 16239641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
    Benyahia C; Boukais K; Gomez I; Silverstein A; Clapp L; Fabre A; Danel C; Leséche G; Longrois D; Norel X
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():48-55. PubMed ID: 23850788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins.
    Orie NN; Ledwozyw A; Williams DJ; Whittle BJ; Clapp LH
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():1-7. PubMed ID: 23872196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry.
    Wang Y; Lu W; Yang K; Wang Y; Zhang J; Jia J; Yun X; Tian L; Chen Y; Jiang Q; Zhang B; Chen X; Wang J
    J Mol Med (Berl); 2015 Mar; 93(3):327-42. PubMed ID: 25391250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of cicaprost-induced desensitization in rat pulmonary artery smooth muscle cells involves a PKA-mediated inhibition of adenylyl cyclase.
    Sobolewski A; Jourdan KB; Upton PD; Long L; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2004 Aug; 287(2):L352-9. PubMed ID: 15107293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization.
    Wilson SJ; Dowling JK; Zhao L; Carnish E; Smyth EM
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):290-6. PubMed ID: 17110599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: Role of membrane versus nuclear receptors.
    Clapp LH; Gurung R
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():56-71. PubMed ID: 25917921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?
    Tuder RM; Zaiman AL
    Am J Respir Cell Mol Biol; 2002 Feb; 26(2):171-4. PubMed ID: 11804866
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.
    Ogo T; Chowdhury HM; Yang J; Long L; Li X; Torres Cleuren YN; Morrell NW; Schermuly RT; Trembath RC; Nasim MT
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):733-41. PubMed ID: 23418342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation.
    Wilson SJ; Roche AM; Kostetskaia E; Smyth EM
    J Biol Chem; 2004 Dec; 279(51):53036-47. PubMed ID: 15471868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of vasodilation mode among selexipag (NS-304; [2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide]), its active metabolite MRE-269 and various prostacyclin receptor agonists in rat, porcine and human pulmonary arteries.
    Fuchikami C; Murakami K; Tajima K; Homan J; Kosugi K; Kuramoto K; Oka M; Kuwano K
    Eur J Pharmacol; 2017 Jan; 795():75-83. PubMed ID: 27919660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
    Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Ikeda T; Nakamura K; Akagi S; Kusano KF; Matsubara H; Fujio H; Ogawa A; Miura A; Miura D; Oto T; Yamanaka R; Otsuka F; Date H; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):39-48. PubMed ID: 19786891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro.
    Yamamura A; Fujitomi E; Ohara N; Tsukamoto K; Sato M; Yamamura H
    Eur J Pharmacol; 2017 Sep; 810():44-50. PubMed ID: 28603047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Akagi S; Nakamura K; Matsubara H; Kusano KF; Kataoka N; Oto T; Miyaji K; Miura A; Ogawa A; Yoshida M; Ueda-Ishibashi H; Yutani C; Ito H
    Int J Cardiol; 2013 May; 165(3):499-505. PubMed ID: 21955608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prostaglandin I2 analogs on cytokine expression in human myeloid dendritic cells via epigenetic regulation.
    Kuo CH; Lin CH; Yang SN; Huang MY; Chen HL; Kuo PL; Hsu YL; Huang SK; Jong YJ; Wei WJ; Chen YP; Hung CH
    Mol Med; 2012 May; 18(1):433-44. PubMed ID: 22231731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.
    Green DE; Murphy TC; Kang BY; Bedi B; Yuan Z; Sadikot RT; Hart CM
    Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L371-L383. PubMed ID: 28522568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of prostacyclin and its analogs in the management of pulmonary arterial hypertension.
    Dandel M; Hetzer R
    Curr Vasc Pharmacol; 2003 Jun; 1(2):171-81. PubMed ID: 15320842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.